Effects of APOE e4-allele and mental work demands on cognitive decline in old age: Results from the German Study on Ageing, Cognition, and Dementia in Primary Care Patients (AgeCoDe).


Journal

International journal of geriatric psychiatry
ISSN: 1099-1166
Titre abrégé: Int J Geriatr Psychiatry
Pays: England
ID NLM: 8710629

Informations de publication

Date de publication:
01 2021
Historique:
received: 12 11 2019
revised: 15 06 2020
accepted: 14 08 2020
pubmed: 21 8 2020
medline: 24 4 2021
entrez: 21 8 2020
Statut: ppublish

Résumé

Previous studies have observed protective effects of high mental demands at work on cognitive functioning and dementia risk. However, it is unclear what types of demands drive this effect and whether this effect is subject to a person's genetic risk. We investigated to what extent eight different types of mental demands at work together with the APOE e4 allele, a major risk gene for late-onset Alzheimer's disease, affect cognitive functioning in late life. The population-based German Study on Ageing, Cognition, and Dementia in Primary Care Patients (AgeCoDe, n = 2 154) followed cognitively healthy individuals aged 75 years and older in seven assessment waves. Cognitive functioning was assessed via the mini-mental status examination. Mixed-effects modeling (adjusted for education, gender, marital status, stroke, depression, and diabetes) indicated that participants who had an occupational history of working in jobs with high compared to low demands in "Language & Knowledge", "Pattern detection", "Information processing", and "Service" had a slower cognitive decline. APOE e4-allele carriers had an accelerated cognitive decline, but this decline was significantly smaller if they had a medium compared to a low level of demands in contrast to non-carriers. Our longitudinal observations suggest that cognitive decline could be slowed by an intellectually enriched lifestyle even in risk gene carriers. Fostering intellectual engagement throughout the life-course could be a key prevention initiative to promote better cognitive health in old age.

Identifiants

pubmed: 32819031
doi: 10.1002/gps.5409
doi:

Substances chimiques

Apolipoprotein E4 0
Apolipoproteins E 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

152-162

Informations de copyright

© 2020 The Authors. International Journal of Geriatric Psychiatry published by John Wiley & Sons Ltd.

Références

Di Marco LY, Marzo A, Munoz-Ruiz M, et al. Modifiable lifestyle factors in dementia: a systematic review of longitudinal observational cohort studies. J Alzheimers Dis. 2014;42(1):119-135.
Valenzuela MJ, Sachdev P. Brain reserve and dementia: a systematic review. Psychol Med. 2006;36(4):441-454.
Then FS, Luck T, Luppa M, et al. Systematic review of the effect of the psychosocial working environment on cognition and dementia. Occup Environ Med. 2014;71(5):358-365.
Salthouse TA. Mental exercise and mental aging evaluating the validity of the "use it or lose it" hypothesis. Perspect Psychol Sci. 2006;1(1):68-87.
Stern Y. Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol. 2012;11(11):1006-1012.
Then FS, Luck T, Heser K, et al. Which types of mental work demands may be associated with reduced risk of dementia? Alzheimers Dement. 2017;13(4):431-440.
Coon KD, Myers AJ, Craig DW, et al. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J Clin Psychiatry. 2007;68(4):613-618.
Cosentino S, Scarmeas N, Helzner E, et al. APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease. Neurology. 2008;70(19 Pt 2):1842-1849.
Wang H-X, Gustafson DR, Kivipelto M, et al. Education halves the risk of dementia due to apolipoprotein ε4 allele: a collaborative study from the Swedish Brain Power initiative. Neurobiol Aging. 2012;33(5):1007-e1001.
Seeman TE, Huang MH, Bretsky P, Crimmins E, Launer L, Guralnik JM. Education and APOE-e4 in longitudinal cognitive decline: MacArthur studies of successful aging. J Gerontol B Psychol Sci Soc Sci. 2005;60(2):P74-P83.
Luck T, Riedel-Heller SG, Kaduszkiewicz H, et al. Mild cognitive impairment in general practice: age-specific prevalence and correlate results from the German study on ageing, cognition and dementia in primary care patients (AgeCoDe). Dement Geriatr Cogn Disord. 2007;24(4):307-316.
Zaudig M, Hiller WSIDAM. Strukturiertes Interview für die Diagnose einer Demenz vom Alzheimer Typ, der Multiinfarkt-(oder vaskulären) Demenz und Demenzen anderer Ätiologie nach DSM-III-R, DSM-IV und ICD-10. 10 Fragebögen. Bern: Huber; 1995.
Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990;31(3):545-548.
König W, Lüttinger P, Müller W. A Comparative Analysis of the Development and Structure of Educational Systems: Methodological Foundations and the Construction of a Comparative Educational Scale. Mannheim, Germany: Universität Mannheim, Institut für Sozialwissenschaften; 1988.
Karp A, Andel R, Parker MG, Wang HX, Winblad B, Fratiglioni L. Mentally stimulating activities at work during midlife and dementia risk after age 75: follow-up study from the Kungsholmen project. Am J Geriatr Psychiatry. 2009;17(3):227-236.
Andel R, Crowe M, Pedersen NL, et al. Complexity of work and risk of Alzheimer's disease: a population-based study of Swedish twins. J Gerontol B Psychol Sci Soc Sci. 2005;60(5):P251-P258.
Wickens CD, Hollands JG, Banbury S, Parasuraman R. Engineering Psychology & Human Performance. New York: Psychology Press; 2015.
Locascio JJ, Growdon JH, Corkin S. Cognitive test performance in detecting, staging, and tracking Alzheimer's disease. Arch Neurol. 1995;52(11):1087-1099.
Summers MJ, Saunders NL. Neuropsychological measures predict decline to Alzheimer's dementia from mild cognitive impairment. Neuropsychology. 2012;26(4):498-508.
Lemerise EA, Arsenio WF. An integrated model of emotion processes and cognition in social information processing. Child Dev. 2000;71(1):107-118.
Tuladhar AM, van Uden IW, Rutten-Jacobs LC, et al. Structural network efficiency predicts conversion to dementia. Neurology. 2016;86(12):1112-1119.
Rodriguez FS, Schroeter ML, Arelin K, et al. APOE e4-genotype and lifestyle interaction on cognitive performance: results of the LIFE-adult-study. Health Psychol. 2018;37(2):194-205.
Wirth M, Villeneuve S, La Joie R, Marks SM, Jagust WJ. Gene-environment interactions: lifetime cognitive activity, APOE genotype, and beta-amyloid burden. J Neurosci. 2014;34(25):8612-8617.
Arenaza-Urquijo EM, Gonneaud J, Fouquet M, et al. Interaction between years of education and APOE epsilon4 status on frontal and temporal metabolism. Neurology. 2015;85(16):1392-1399.
Dekhtyar S, Marseglia A, Xu W, Darin-Mattsson A, Wang HX, Fratiglioni L. Genetic risk of dementia mitigated by cognitive reserve: a cohort study. Ann Neurol. 2019;86(1):68-78.
Garibotto V, Borroni B, Sorbi S, Cappa S, Padovani A, Perani D. Education and occupation provide reserve in both ApoE ε4 carrier and noncarrier patients with probable Alzheimer's disease. Neurol Sci. 2012;33(5):1037-1042.
Smart EL, Gow AJ, Deary IJ. Occupational complexity and lifetime cognitive abilities. Neurology. 2014;83(24):2285-2291.
Gow AJ, Johnson W, Pattie A, Whiteman MC, Starr J, Deary IJ. Mental ability in childhood and cognitive aging. Gerontology. 2008;54(3):177-186.
Gow AJ, Corley J, Starr JM, Deary IJ. Reverse causation in activity-cognitive ability associations: the Lothian birth cohort 1936. Psychol Aging. 2012;27(1):250-255.
Lourida I, Hannon E, Littlejohns TJ, et al. Association of lifestyle and genetic risk with incidence of dementia. JAMA. 2019;322(5):430-437.
Licher S, Ahmad S, Karamujić-Čomić H, et al. Genetic predisposition, modifiable-risk-factor profile and long-term dementia risk in the general population. Nat Med. 2019;25(9):1364-1369.
Hedeker D, Gibbons RD. Application of random-effects pattern-mixture models for missing data in longitudinal studies. Psychol Methods. 1997;2(1):64-78.
Napierala MA. What is the Bonferroni correction. AAOS Now. 2012;6(4):40.
Garamszegi LZ. Comparing effect sizes across variables: generalization without the need for Bonferroni correction. Behav Ecol. 2006;17(4):682-687.

Auteurs

Francisca S Rodriguez (FS)

Institute of Social Medicine, Occupational Health and Public Health (ISAP), University of Leipzig, Leipzig, Germany.
German Center for Neurodegenerative Diseases (DZNE), Research Group Psychosocial Epidemiology and Public Health, Greifswald, Germany.

Susanne Roehr (S)

Institute of Social Medicine, Occupational Health and Public Health (ISAP), University of Leipzig, Leipzig, Germany.

Alexander Pabst (A)

Institute of Social Medicine, Occupational Health and Public Health (ISAP), University of Leipzig, Leipzig, Germany.

Luca Kleineidam (L)

Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
DZNE, German Center for Neurodegenerative Diseases, Bonn, Germany.

Angela Fuchs (A)

Institute of General Practice, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

Birgitt Wiese (B)

Work Group Medical Statistics and IT-Infrastructure, Institute for General Practice, Hannover Medical School, Hannover, Germany.

Dagmar Lühmann (D)

Department of Primary Medical Care, Center for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Christian Brettschneider (C)

Department of Health Economics and Health Services Research, Hamburg Center for Health Economics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Steffen Wolfsgruber (S)

Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
DZNE, German Center for Neurodegenerative Diseases, Bonn, Germany.

Michael Pentzek (M)

Institute of General Practice, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

Hendrik van den Bussche (H)

Department of Primary Medical Care, Center for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Hans-Helmut König (HH)

Department of Health Economics and Health Services Research, Hamburg Center for Health Economics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Siegfried Weyerer (S)

Central Institute of Mental Health, Medical Faculty, Mannheim/Heidelberg University, Heidelberg, Germany.

Jochen Werle (J)

Central Institute of Mental Health, Medical Faculty, Mannheim/Heidelberg University, Heidelberg, Germany.

Horst Bickel (H)

Department of Psychiatry, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Dagmar Weeg (D)

Department of Psychiatry, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Wolfgang Maier (W)

Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
DZNE, German Center for Neurodegenerative Diseases, Bonn, Germany.

Martin Scherer (M)

Department of Primary Medical Care, Center for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Michael Wagner (M)

Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
DZNE, German Center for Neurodegenerative Diseases, Bonn, Germany.

Steffi G Riedel-Heller (SG)

Institute of Social Medicine, Occupational Health and Public Health (ISAP), University of Leipzig, Leipzig, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH